TECH Stock: Price, Earnings History and SEC Filings
Bio-Techne Corporation (TECH) last traded at $72.66, down 0.07% on the latest session and up 0.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.49 against an analyst estimate of $0.46, a beat of 6.5%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
TECH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 12, 2026 | $0.49 | $0.46 | +6.52% |
| Mar 2026 | May 6, 2026 | $0.48 | $0.48 | +0.00% |
| Dec 2025 | Feb 4, 2026 | $0.39 | $0.34 | +14.71% |
| Sep 2025 | Nov 5, 2025 | $0.36 | $0.36 | +0.00% |
TECH beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How TECH reacts to earnings
Across its last 8 earnings releases, TECH moved 5.8% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-12 | Before open | +0.11% |
| 2026-05-06 | Before open | -16.35% |
| 2026-02-04 | Before open | +6.25% |
| 2025-11-05 | Before open | -1.90% |
| 2025-08-06 | Before open | -8.73% |
| 2025-05-07 | Before open | +2.16% |
| 2025-02-05 | Before open | +3.72% |
| 2024-10-30 | Before open | +7.46% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
TECH financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $1.2B | – | $263M | – | $1.16 |
| 2025 | $1.2B | $73M | $257M | 6.0% | $0.46 |
| 2024 | $1.2B | $168M | $236M | 14.5% | $1.05 |
| 2023 | $1.1B | $285M | $216M | 25.1% | $1.76 |
| 2022 | $1.1B | $272M | $280M | 24.6% | $1.66 |
| 2021 | $931M | $140M | $308M | 15.1% | $0.87 |
| 2020 | $739M | $229M | $153M | 31.0% | $5.82 |
| 2019 | $714M | $96M | $156M | 13.5% | $2.47 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for TECH
- 8-K · Sep 23, 2026Shareholder vote, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Sep 14, 2026Other events
- 10-K · Aug 24, 2026
- 8-K · Aug 12, 2026Results of operations, Other events, Financial statements and exhibits
- 8-K · Jun 26, 2026Material agreement, Officer or director change, Financial statements and exhibits
- 8-K · Jun 25, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · May 6, 2026
- 8-K · May 6, 2026Results of operations, Other events, Financial statements and exhibits
- 8-K · Feb 11, 2026Officer or director change, Other events, Financial statements and exhibits
- 10-Q · Feb 4, 2026
Insider filing activity
TECH insiders filed 14 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
TECH news
- Alphabet tumbles, software and cybersecurity stocks sink as earnings disappoint: AlphaCheckOct 29, 2026 · finance.yahoo.com
- 1 healthcare stock for long-term investors and 2 we ignoreOct 26, 2026 · finance.yahoo.com
- What You Need to Know Ahead of Bio-Techne’s Earnings ReleaseOct 26, 2026 · barchart.com
About Bio-Techne Corporation
Bio-Techne Corporation (TECH) is a US-listed public company on Nasdaq. The SEC classifies its business as Biological Products (no Diagnostic Substances). It is incorporated in MN. Its fiscal year ends in June.